AEON Biopharma, Inc. (AEON)
CIK 1837607 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 49.9M shares as of Aug 6, 2026 (10-Q). Share count fell from 11.3M to 1.2M between May 7, 2025 and Aug 8, 2025, a pattern consistent with a reverse split (roughly 1-for-10); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Pre Funded Warrant | 24.8M | not tagged | — | — |
| Daewong Warrant | 8.0M | $1.09392 | 5y | FV $5.2M |
| Pipe Warrants | 6.5M | $1.09392 | 5y | — |
| Two Year Milestone Warrant | 6.4M | not tagged | — | — |
| Five Year Milestone Warrant | 6.4M | not tagged | — | — |
| Seriesa Warrants | 3.6M | $45 | 5y | — |
| Odean Warrants | 125,000 | $2 | 3y | FV $100,000 |
| Series B Warrants | 62,263 | $45 | 2.5y | — |
| Private Placement Warrants | 55,403 | not tagged | — | — |
| Pipe Pre Funded Warrants | not tagged | $0.0001 | — | — |
| True Up Warrants | not tagged | $0.0001 | — | — |
| Pre Funded Warrants | not tagged | $0.0001 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 12, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 55,403 underlying shares, as reported Dec 31, 2024 (10-K).
Reported exercise price: $2 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $11.4M as of Jun 30, 2026.
Rough fully diluted estimate: 49.9M = 49.9M O/S + 55,403 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| Convertible Notes Maturing On April 2027 | $10.0M | — | not tagged | — | — |
| Convertible Notes Maturing On March 2027 | $5.0M | — | not tagged | — | — |
| New Convertible Note Issued In Lie of Exchange | not tagged | $1.5M | not tagged | — | — |
Notes exactly as the company dimensioned them in its 10-Q filed Aug 12, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 49.9M | Aug 6, 2026 |
| + Pre Funded Warrant (if exercised) | 24.8M | Jul 13, 2026 |
| + Daewong Warrant (if exercised) | 8.0M | Jun 30, 2026 |
| + Pipe Warrants (if exercised) | 6.5M | Jun 30, 2026 |
| + Two Year Milestone Warrant (if exercised) | 6.4M | Jul 14, 2026 |
| + Five Year Milestone Warrant (if exercised) | 6.4M | Jul 14, 2026 |
| + Seriesa Warrants (if exercised) | 3.6M | Jun 30, 2026 |
| + Odean Warrants (if exercised) | 125,000 | Jun 30, 2026 |
| + Series B Warrants (if exercised) | 62,263 | Jun 30, 2026 |
| + Private Placement Warrants (if exercised) | 55,403 | Jun 30, 2026 |
| Fully diluted estimate | 105.8M | +112.2% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $97.5Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 4 executed · 4 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full AEON workspace